Comparison of olanzapine and quetiapine antipsychotic treatments of schizophrenia: 6-month results from the 3-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study

被引：0

|

作者：

Morrison, S

O'Halloran, RA

Boland, J

Dossenbach, M

Mahuad, R

Gastiaburu, CO

机构：

来源：

AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY | 2003年 / 37卷

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

收藏

页码：A10 / A11

页数：2

相关论文

共 50 条

[1] Comparison of olanzapine and quetiapine antipsychotic treatments of schizophrenia: 6-month results from the 3-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
Morrison, S
O'Halloran, RA
Boland, J
Dossenbach, M
Mahuad, R
Gastiaburu, CO
[J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2003, 37 : A12 - A13
[2] Comparison of olanzapine and quetiapine antipsychotic treatments for schizophrenia: Six-month results from the three-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
Boland, J
O'Halloran, RA
Dossenbach, M
Levitt, L
Enatescu, V
Simon, L
Janu, L
[J]. SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 274 - 274
[3] Effectiveness of antipsychotic treatments for patients from the Central Eastern Europe (CEE) region participating in the 3-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study:: 6-Month results
Pecenák, J
Kaps, P
Treuer, T
Bitter, I
Hodge, A
Grigoriu, A
Trzebiatowska, I
Herman, E
Peciukaitiene, D
Smulevich, A
Kökényes, M
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S307 - S308
[4] Change in clinical status and side effects of patients treated with either olanzapine or risperidone: 6-month results from the 3-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) observational study
O'Halloran, RA
Boland, J
Lee, PG
Dossenbach, M
Kim, CE
Jon, DI
[J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2003, 37 : A11 - A11
[5] Change in clinical status and side effects of patients treated with either olanzapine or risperidone: 6-month results from the 3-year intercontinental schizophrenia outpatient health outcomes (ic-soho) observational study
Osnayo, JL
Ibarra, RR
O'Halloran, RA
Boland, JM
Brunner, E
Levitt, L
Dossenbach, M
[J]. BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 28S - 29S
[6] Baseline results of patients initiating treatment with olanzapine or risperidone in the 3-year intercontinental schizophrenia outpatient health outcomes (IC-SOHO) study
Levitt, L
Becker, S
Boland, J
Rodriguez, I
Dossenbach, M
Schawoush, M
Granim, M
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S327 - S327
[7] Effectiveness of antipsychotic treatments for schizophrenia: Interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol
Dossenbach, M
Erol, A
Kessaci, ME
Shaheen, MO
Sunbol, MM
Boland, J
Hodge, A
O'Halloran, RA
Bitter, I
[J]. JOURNAL OF CLINICAL PSYCHIATRY, 2004, 65 (03) : 312 - 321
[8] Mortality in a cohort of outpatients with schizophrenia: 3-year outcomes from the intercontinental outpatient health outcomes study (IC-SOHO)
Hoffmann, Vicki Poole
Dossenbach, Martin
West, Teena M.
Lowry, Amanda J.
[J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 163S - 164S
[9] Patterns of antipsychotic-induced weight change: 3-year results from the intercontinental schizophrenia outpatient-health outcomes (IC-SOHO) study
Dossenbach, M.
Pachecho, Z.
Toledo, D.
Cornejo, R.
West, T.
Lowry, A.
[J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S407 - S408
[10] Extrapyramidal symptoms among patients with schizophrenia treated with olanzapine or other antipsychotics: 6-month results of the Intercontinental Schizophrenia Outpatient Health Outcomes study - IC-SOHO (Polish sample)
Debowska, G
Meder, J
Lis, J
Szulc, A
[J]. EUROPEAN PSYCHIATRY, 2004, 19 : 173S - 173S

← 1 2 3 4 5 →